Immunomedics Stock Has Its Sights Set on Higher Prices

IMMU Stock: Bullish on Multiple Time Frames The focus of this publication is Immunomedics, Inc. (NASDAQ: IMMU) stock. This clinical stage biotechnology company develops treatments to boost the body's antibodies in order to fight serious diseases like cancer and autoimmune disorders. I have mentioned in a number of publications that the biotechnology stock sector has begun to perk up, and IMMU stock is no exception. I am bullish on the stock because the method of analysis I employ to generate a v...